Vimarsana
Biggest News Aggregation in the World

Page 3 - Breakthrough Device Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Breakthrough Device Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Breakthrough Device Program Today - Breaking & Trending Today

Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone - Vimarsana News

Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone

Orthospinenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from orthospinenews.com Daily Mail and Mail on Sunday newspapers.

Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone - Vimarsana News

Anika Completes Enrollment in Hyalofast® U.S. Pivotal Phase III Study Achieving Key Milestone

Hyalofast – a single-stage, off-the-shelf, resorbable, hyaluronic acid scaffold for cartilage repair – is marketed in over 35 countries outside the U.S. where it has been... | May 30, 2023

Locate Bio receives FDA breakthrough designation for spinal fusion treatment - Vimarsana News

Locate Bio receives FDA breakthrough designation for spinal fusion treatment

Locate Bio, a UK-based orthobiologics company, has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Device designation for LDGraft.

Locate Bio's LDGraft Granted FDA Breakthrough Device Designation - Vimarsana News

Locate Bio's LDGraft Granted FDA Breakthrough Device Designation

LDGraft is a next-generation bone graft substitute for spinal fusion, with uniquely encapsulated rhBMP-2 for controlled and extended-release Seeking to target significant and growing chronic low

VolitionRx Limited Announces First Quarter 2023 Financial Results and Business Update - Vimarsana News

VolitionRx Limited Announces First Quarter 2023 Financial Results and Business Update

Conference call to discuss financial and operational results scheduled for Thursday, May 11, at 8:30 a.m. U.S. Eastern Time HENDERSON, Nev., May 10, 2023 /PRNewswire/ -- VolitionRx Limited (NYSE